Pure Global

Drug test, quantitative test standard NT-proBNP - Vietnam Registration 2402951ĐKLH/BYT-HTTB

Access comprehensive regulatory information for Drug test, quantitative test standard NT-proBNP in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2402951ĐKLH/BYT-HTTB and manufactured by Siemens Healthcare Diagnostics Inc. The authorized representative in Vietnam is CÔNG TY TNHH SIEMENS HEALTHCARE.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
2402951ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2402951ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Drug test, quantitative test standard NT-proBNP
VN: Thuốc thử, chất hiệu chuẩn xét nghiệm định lượng NT-proBNP
Risk Class TTBYT Loại C

Registration Details

2402951ĐKLH/BYT-HTTB

000.00.04.G18-231115-0014

Theo theo phụ lục

Theo phụ lục

Company Information

Theo theo phụ lục

Siemens Healthcare Diagnostics Inc

Technical Details

The ADVIA Centaur NT-proBNP (PBNP) test is an in vitro diagnostic test used to quantify the concentration of N-terminal pro-brain natriuretic peptide (NT-proBNP) in human serum and plasma on the ADVIA Centaur CP, ADVIA Centaur XP, and ADVIA Centaur XPT systems. In patients suspected of having congestive heart failure (CHF), measurements of NT-proBNP are used to aid in diagnosis and to assess the severity of the condition.

Dates and Status

Oct 22, 2024